Back to the main directory
EarningsReview / Equity
- Trust the ‘process’ by BNP Paribas Exane
- Strong guide to start 2025, leasing levels remain impressive by BNP Paribas Exane
- Alfa Laval - Sell/SEK 360: Thesis intact with Marine orders weakening ahead by Nordea
- Demant - Hold: Another back-end-loaded year ahead by Nordea
- Underwhelming and back-end-loaded 2025 by BNP Paribas Exane
- A Coherent Signal For Growth by BNP Paribas Exane
- Equinor - Buy/NOK 315 (Hold): Higher-for-longer core earnings take centre stage by Nordea
- Munters - Buy/SEK 209 (235): Strong orders offset by weak margins by Nordea
- FQ1 results first take - in-line quarter, no change to guidance by BNP Paribas Exane
- Swedish Orphan Biovitrum - It’s all about good launches in 2025 by Danske Bank Equity Research
- 2025 Guide Calls for a Rollercoaster Ride by BNP Paribas Exane
- Ringkjoebing Landbobank - Buy/DKK 1,270 (Hold): From fairly valued to undervalued by Nordea
- Pandora - Hold: Entering 'efficiency mode' by Nordea
- Svenska Handelsbanken - Core profit improvement and high capital return by Danske Bank Equity Research
- Swiggy Ltd (SWIGGY IN) by HSBC
- Sampo 4Q24 First Take: Headline beat, soft guidance by BNP Paribas Exane
- Q4 24 results coming short of consensus by BNP Paribas Exane
- January 2025 P&C renewals: lower risk-adjusted prices, higher volumes by BNP Paribas Exane
- FY24 results: FY sales & EPS in line, but implied H2 LFL a touch below cons by BNP Paribas Exane
- Q424 results: EBITA in line, FCF strong by BNP Paribas Exane
- FY24 results first take by BNP Paribas Exane
- 4Q24 production - Copper better than feared, diamond impairment coming by BNP Paribas Exane
- ING GROEP: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- 3Q25 Trading Update: Not much information, re-iterate FY 2025 guidance by BNP Paribas Exane
- Scandi Standard - Pas d’amélioration des marges sur le dernier trimestre, comme attendu by MidCap Partners